Skip to main content
Caplight Logo









Iris Medicine

Iris Medicine

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://irismedicine.com/

Last Round

Grant

Sep 25, 2025

Total Funding Raised

$3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Iris Medicine is a biotechnology company that develops a ribonucleic acid therapeutics platform designed to treat genetic diseases using small binding RNA (sbRNA) technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small binding RNAsbRNARNA therapeuticsrepeat expansion disordersallele-selective targetinggene expression regulationbiotech drug discoveryHuntington's diseaseALSRNA medicinegenetic disease treatmentbiotech licensingdrug pipelineneurological therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Iris Medicine Comparables

Compare Iris Medicine with similar companies based on industry and business-model similarity.

Iris Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Switch Therapeutics
83%
Vico Therapeutics
76%
Wave Life Sciences
72%

Iris Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 25, 2025
SeedMay 1, 2020

Iris Medicine Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 43% MoM.

  • Jul 25, 2026

    Monthly visitors increased 60% MoM, reaching 1.3K.

Iris Medicine Filings

Explore SEC and related filing metadata, where available.

Iris Medicine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Iris Medicine's valuation, stock price, and market status.

Is Iris Medicine a public or private company?

Iris Medicine is a private company.

What is the current stock price of Iris Medicine?

Iris Medicine is a private company with no public stock price. No recent secondary market data is available.

How much is Iris Medicine worth (valuation)?

Valuation information for Iris Medicine is not publicly available.

Can I buy Iris Medicine stock?

Iris Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Iris Medicine's last funding round?

Iris Medicine's most recent funding round was Grant on September 28, 2025.

Who are the main investors in Iris Medicine?

Key investors in Iris Medicine include California Institute for Regenerative Medicine, Venrock.

Will Iris Medicine IPO soon?

No public IPO plans have been announced for Iris Medicine.

How can I track Iris Medicine secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Iris Medicine's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range11
Year Founded2019
Last FundingSep 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?